Framatome has officially opened a new facility in Romans-sur-Isère, France, focusing on the fabrication of fuel for research reactors and medical radioisotope targets. This expansion, part of Framatome's investment strategy, replaces the existing uranium zone with upgraded equipment aimed at enhancing production processes. The facility will secure fuel supplies for research reactors and medical-use targets for decades, according to Lionel Gaiffe, a senior executive at the company. Framatome's division CERCA is a leading supplier of research reactor fuel, responsible for producing over 20,000 fuel elements globally, and providing the majority of medical radioisotope targets used in technetium-99m scans, which are essential in nuclear medicine imaging.
Tue, 22 Apr 2025 10:25:21 GMT | NucNet